Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003CLI-II)

This study has been completed.
ViroMed Co., Ltd. dba VM BioPharma
Information provided by (Responsible Party):
Beijing Northland Biotech. Co., Ltd. Identifier:
First received: March 5, 2012
Last updated: March 23, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)